Sylvie Ryckebusch

Sylvie Ryckebusch is an independent member of the Board of Directors at Kainova Therapeutics. She brings more than twenty years of experience in business development, alliance management, and corporate strategy.

Dr Ryckebusch currently serves as Chief Business Officer of BioInvent International and is a founder of Octave Biotech S.A. based in Geneva, Switzerland, a firm supporting life sciences companies in business development strategy and execution. Sylvie is also an Adjunct Professor at the Grenoble School of Management.

Earlier in her career, Dr Ryckebusch held leadership roles at Serono, Merck KGaA, where she was involved in multiple product and technology transactions and the creation of several startup ventures. Before entering the pharmaceutical industry, she spent four years with McKinsey & Company.

Sylvie Ryckebusch holds a PhD in neurobiology from the California Institute of Technology and completed a postdoctoral fellowship at Harvard Business School.